Skip to main content
SBFM
NASDAQ Life Sciences

Sunshine Biopharma COO Resigns Immediately Amidst 52-Week Lows

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.151
Mkt Cap
$5.642M
52W Low
$1.15
52W High
$3.9
52W Position info
0.1% above low
Off High info
70% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

SBFM is trading near its 52-week low of $1.15 (0.1% above the low).

Summary

Sunshine Biopharma Inc. announced the immediate resignation of its Chief Operating Officer, Dr. Abderrazzak Merzouki, a significant executive departure for the nano-cap company.


Key Events · Executive and Board Changes · SBFM

  • Chief Operating Officer Resigns

    Dr. Abderrazzak Merzouki resigned as Chief Operating Officer of Sunshine Biopharma Inc., effective immediately, on February 5, 2026.


Analysis · SBFM · Life Sciences

The immediate resignation of a key C-suite executive like the Chief Operating Officer, Dr. Abderrazzak Merzouki, is a notable negative development for Sunshine Biopharma, especially given its nano-cap status. For small companies, the stability and continuity of leadership are crucial, and an abrupt departure can signal underlying issues or create operational uncertainty. This news comes as the company's stock is trading at its 52-week low, potentially intensifying negative investor sentiment and raising questions about the company's strategic direction and operational health. Investors will be watching for any further details regarding the reasons for the resignation and plans for a replacement.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SBFM was trading at $1.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.6M. The 52-week trading range was $1.15 to $3.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SBFM - Latest Insights

SBFM
Nov 18, 2026, 4:05 PM EST
Filing Type: S-1
Importance Score:
7
Price at Filing: $2.41
Real-time Price: $2.30 info
Change: -$0.1099 (-5%) info
Market Cap: $1.985M info
SBFM
Nov 12, 2026, 11:56 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $2.30 info
Change: -$0.3999 (-15%) info
Market Cap: $1.985M info
SBFM
Nov 12, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $2.30 info
Change: -$0.5099 (-18%) info
Market Cap: $1.985M info
SBFM
Nov 12, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.80
Real-time Price: $2.30 info
Change: -$0.4999 (-18%) info
Market Cap: $1.985M info
SBFM
Oct 22, 2026, 9:25 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.1638
Real-time Price: $2.30 info
Change: Reverse Stock Split info
Market Cap: $1.985M info